NSE · SUNPHARMA.NS
Sun Pharmaceutical Industries Limited
₹1,811.30+₹50.30 (+2.86%)
Sun Pharmaceutical Industries Limited’s quoted price sits in the lower half of its reported 52-week range, 11.48% below the high.
Loading market information…
NSE · DCAL.NS · INR
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 07:17 AM UTC. Cached market data; not a live quote.
One-year closing-price history · INR. Historical prices are not a forecast.
Dishman Carbogen Amcis Limited’s quoted price sits in the lower half of its reported 52-week range, 51.45% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Dishman Carbogen Amcis Limited’s forward annual dividend is ₹1.20 per share, paid annual. The forward yield is 0.82% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Dishman Carbogen Amcis Limited’s next earnings report is currently expected on Nov 5, 2026. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Dishman Carbogen Amcis Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Established in 1983 and headquartered in Ahmedabad, India, Dishman Carbogen Amcis Limited provides specialized contract research and manufacturing solutions to the worldwide pharmaceutical sector. The company operates through two main business segments: Contract Research and Manufacturing Services (CR&MS), and Marketable Molecules. Beyond its core services, it manufactures and distributes an extensive portfolio of products, including bulk drugs, chemical intermediates, various phase transfer catalysts, quaternary ammonium compounds, phosphoranes, wittig reagents, vitamin D derivatives, and fine chemicals. Additionally, its offerings encompass personal care products like hand and body washes, sanitizers, and antiseptics, as well as a range of pharmaceutical and cosmetic formulations, including generic and highly potent active pharmaceutical ingredients. Dishman Carbogen Amcis Limited is a subsidiary of Adimans Technologies LLP.
Latest available per-share figures in INR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 07:18 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| Q3 2025 | Feb 12, 2025 | ₹0.30 | ₹6.82B |
|---|
| Q2 2025 | Nov 13, 2024 | ₹2.11 | ₹7.89B-73.56% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
₹1,811.30+₹50.30 (+2.86%)
Sun Pharmaceutical Industries Limited’s quoted price sits in the lower half of its reported 52-week range, 11.48% below the high.
₹9,811.00+₹147.00 (+1.52%)
Divi's Laboratories Limited’s quoted price sits in the upper half of its reported 52-week range, 0.35% below the high.
₹855.20-₹14.10 (-1.62%)
Supriya Lifescience Limited’s quoted price sits in the upper half of its reported 52-week range, 21.18% below the high.
₹1,039.40-₹11.70 (-1.11%)
Innova Captab Limited’s quoted price sits in the upper half of its reported 52-week range, 23.21% below the high.
₹260.65-₹3.55 (-1.34%)
Suven Life Sciences Limited’s quoted price sits in the lower half of its reported 52-week range, 35.38% below the high.
₹178.09-₹4.89 (-2.67%)
Sun Pharma Advanced Research Company Limited’s quoted price sits in the lower half of its reported 52-week range, 38.37% below the high.
₹442.40-₹6.60 (-1.47%)
Aarti Drugs Limited’s quoted price sits in the upper half of its reported 52-week range, 17.15% below the high.
₹1,307.00-₹16.60 (-1.25%)
Zota Health Care Limited’s quoted price sits in the lower half of its reported 52-week range, 24.89% below the high.
